← Back to Search

Behavioural Intervention

Neurofeedback (from fMRI and/or EEG) for Nicotine Addiction

N/A
Waitlist Available
Led By R. Alison Adcock, MD, PhD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Right handed
In good general health
Timeline
Screening 3 weeks
Treatment Varies
Follow Up changes will be assessed across the task (~30 minutes) during the neurofeedback visit
Awards & highlights

Study Summary

This trial aims to see if a non-medication intervention can increase motivation for non-drug rewards (like a favorite food) for people with and without nicotine dependence.

Eligible Conditions
  • Nicotine Addiction

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You need to be right-handed.
Select...
You are overall healthy.
Select...
Anyone, regardless of gender.
Select...
If you are a non-diabetic person, you smoke at least 5 regular cigarettes daily, according to your own statement.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~to occur following the neurofeedback session, up to 30 minutes following the session
This trial's timeline: 3 weeks for screening, Varies for treatment, and to occur following the neurofeedback session, up to 30 minutes following the session for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in reward-related brain activation
Secondary outcome measures
Dopamine availability
Onset to smoking a cigarette

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Reward-related Brain Region FeedbackExperimental Treatment1 Intervention
Participants in this group will receive neurofeedback from a reward-related brain area (e.g., VTA, PFC) using EEG and/or fMRI during the experiment.
Group II: Noise ControlPlacebo Group1 Intervention
Participants in this group will receive sham neurofeedback. Participants will be debriefed at the end of the study.

Find a Location

Who is running the clinical trial?

Brain & Behavior Research FoundationOTHER
61 Previous Clinical Trials
2,766 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
316 Previous Clinical Trials
390,606 Total Patients Enrolled
1 Trials studying Nicotine Addiction
8 Patients Enrolled for Nicotine Addiction
National Institutes of Health (NIH)NIH
2,679 Previous Clinical Trials
6,910,635 Total Patients Enrolled
2 Trials studying Nicotine Addiction
280 Patients Enrolled for Nicotine Addiction

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor still recruiting participants?

"Affirmative. Clinicaltrials.gov attests that this clinical trial is actively recruiting participants, with the study initially posted on February 28th 2018 and most recently updated on January 28th 2022. Currently, 100 individuals need to be recruited from a single location for this medical research."

Answered by AI

What is the enrollment capacity of this clinical study?

"Affirmative. According to the information from clinicaltrials.gov, this medical trial is currently in need of 100 participants across a single site. The project was first posted on February 28th 2018 and recently modified on January 28th 2022."

Answered by AI

Who is eligible to participate in this scientific investigation?

"This trial seeks to enroll up to 100 nicotine-dependent individuals in the 18-45 age bracket."

Answered by AI

Does the age requirement of this clinical trial include participants younger than 25?

"The trial is looking for participants aged between 18 and 45 years."

Answered by AI
~7 spots leftby Mar 2025